Cargando…
FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
FOXC1 is a member of Forkhead box transcription factors that participates in embryonic development and tumorigenesis. Our previous study demonstrated that FOXC1 was highly expressed in triple‐negative breast cancer. However, it remains unclear what is the relation between FOXC1 and ERα and if FOXC1...
Autores principales: | Wang, Jinhua, Xu, Yali, Li, Li, Wang, Lin, Yao, Ru, Sun, Qiang, Du, Guanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269562/ https://www.ncbi.nlm.nih.gov/pubmed/28028927 http://dx.doi.org/10.1002/cam4.990 |
Ejemplares similares
-
Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice
por: Zhang, Zhi, et al.
Publicado: (2021) -
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017) -
Targeting mutant estrogen receptors
por: Wardell, Suzanne E, et al.
Publicado: (2019) -
Apolipoproteins and cancer
por: Ren, Liwen, et al.
Publicado: (2019) -
SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway
por: Xing, Jilin, et al.
Publicado: (2019)